Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CA2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | HIKESHI | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | VASN | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | AJUBA | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
mRNA | SMARCC2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | NUDT13 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | STX2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
mRNA | S100A11 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
mRNA | UBE2E2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | HACD1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |